Trials

T-cell therapy for patients with malignant melanoma

Cancer type: Melanoma

Phase: I/II

Principal Investigator: Svane Inge Marie

Country: DK

Keywords: Denmark, Herlev, T-cell therapy, malignant melanoma, immunotherapy

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/results?term=NCT00937625